CS logo
small CS logo
Fujian Medical University Union Hospital

Fuzhou, Fujian, China
福州市的医院

About Fujian Medical University Union Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Fujian Medical University
45
Fujian Medical University Union Hospital
18
BeiGene
15
Hoffmann-La Roche
15
Janssen Research & Development, LLC
11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
8
Jiangsu HengRui Medicine Co., Ltd.
7
Celgene
4
Eye & ENT Hospital of Fudan University
4
Bayer
3
Beijing InnoCare Pharma Tech Co., Ltd.
3
Total Rows: 89

Clinical Trials at Fujian Medical University Union Hospital


During the past decade, Fujian Medical University Union Hospital conducted 207 clinical trials. In the 10-year time frame, 207 clinical trials started and 29 clinical trials were completed, i.e. on average, 14% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 19 clinical trials were completed. i.e. 21.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years151515152828383824243131292927271100331155448866Started TrialsCompleted Trails2015201620172018201920202021202202040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
2007-03-07
2013-03-28
Completed
527
Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy
2008-12-01
2009-12-01
Completed
404
Acarbose Cardiovascular Evaluation Trial
2009-02-17
2017-04-18
Completed
6,526
Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
2009-10-01
2016-08-01
Unknown status
480
RESOLUTE China Registry:
2010-12-01
2017-12-15
Completed
1,800
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804

Rows per page:

1–100 of 239

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Fujian Medical University Union Hospital" #1 sponsor was "Fujian Medical University" with 45 trials, followed by "Fujian Medical University Union Hospital" with 18 trials sponsored, "BeiGene" with 15 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored and "Janssen Research & Development, LLC" with 15 trials sponsored. Other sponsors include 130 different institutions and companies that sponsored additional 89 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fujian Medical University Union Hospital" #1 collaborator was "Fujian Medical University Union Hospital" with 13 trials as a collaborator, "Chinese PLA General Hospital" with 9 trials as a collaborator, "RenJi Hospital" with 7 trials as a collaborator, "The First Affiliated Hospital of Nanchang University" with 7 trials as a collaborator and "The First Hospital of Jilin University" with 7 trials as a collaborator. Other collaborators include 420 different institutions and companies that were collaborators in the rest 242 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFujian Medical University: 45Fujian Medical University: 45Fujian MedicalUniversity UnionHospital: 18Fujian MedicalUniversity UnionHospital: 18BeiGene: 15BeiGene: 15Hoffmann-La Roche: 15Hoffmann-La Roche: 15Janssen Research &Development, LLC: 11Janssen Research &Development, LLC: 11Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 8Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 8Jiangsu HengRuiMedicine Co., Ltd.: 7Jiangsu HengRuiMedicine Co., Ltd.: 7Celgene: 4Celgene: 4Eye & ENT Hospital ofFudan University: 4Eye & ENT Hospital ofFudan University: 4Bayer: 3Bayer: 3

Created with Highcharts 11.1.0Top CollaboratorsFujian MedicalUniversity UnionHospital: 13Fujian MedicalUniversity UnionHospital: 13Chinese PLA General Hospital: 9Chinese PLA General Hospital: 9RenJi Hospital: 7RenJi Hospital: 7The First AffiliatedHospital of NanchangUniversity: 7The First AffiliatedHospital of NanchangUniversity: 7The First Hospital of JilinUniversity: 7The First Hospital of JilinUniversity: 7West China Hospital: 6West China Hospital: 6Cancer Institute andHospital, ChineseAcademy of MedicalSciences: 5Cancer Institute andHospital, ChineseAcademy of MedicalSciences: 5First Affiliated HospitalXi'an JiaotongUniversity: 5First Affiliated HospitalXi'an JiaotongUniversity: 5Fudan University: 5Fudan University: 5Guangdong ProvincialPeople's Hospital: 5Guangdong ProvincialPeople's Hospital: 5

Clinical Trials Conditions at Fujian Medical University Union Hospital


According to Clinical.Site data, the most researched conditions in "Fujian Medical University Union Hospital" are "Gastric Cancer" (15 trials), "Stomach Neoplasms" (13 trials), "Breast Cancer" (11 trials), "Coronary Artery Disease" (6 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Fujian Medical University Union Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Fujian Medical University Union Hospital


Most popular intervention types in "Fujian Medical University Union Hospital" are "Drug" (156 trials), "Procedure" (39 trials), "Biological" (16 trials), "Other" (13 trials) and "Device" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (32 trials), "Tislelizumab" (10 trials), "Cyclophosphamide" (8 trials), "Carboplatin" (6 trials) and "Doxorubicin" (6 trials). Other intervention names were less common.

Clinical Trials Genders at Fujian Medical University Union Hospital


The vast majority of trials in "Fujian Medical University Union Hospital" are 228 trials for "All" genders, 6 trials for "Male" genders and 5 trials for "Female" genders.

Clinical Trials Status at Fujian Medical University Union Hospital


Currently, there are 125 active trials in "Fujian Medical University Union Hospital". 7 are not yet recruiting, 68 are recruiting, 41 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 48 completed trials in Fujian Medical University Union Hospital, 1 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Fujian Medical University Union Hospital, 11 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 38 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 103Phase 3: 103Phase 2: 71Phase 2: 71Not Applicable: 38Not Applicable: 38Phase 1: 11Phase 1: 11Phase 4: 6Phase 4: 6

Created with Highcharts 11.1.0Trials StatusRecruiting: 68Recruiting: 68Unknown status: 60Unknown status: 60Completed: 48Completed: 48Active, not recruiting: 41Active, not recruiting: 41Enrolling by invitation: 9Enrolling by invitation: 9Not yet recruiting: 7Not yet recruiting: 7Terminated: 4Terminated: 4Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1